| 000 | 01896cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223031227.0 | ||
| 008 | 150516s2014 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.01.Ph.D.2014.He.U | ||
| 100 | 0 | _aHeba Mahmoud Raafat | |
| 245 | 1 | 4 |
_aThe use of dexmedetomidine as an adjuvant for pre-eclamptic patients undergoing cesarean section under general anesthesia / _cHeba Mahmoud Raafat ; Supervised Nadia Youssef Helmy , Jehan Helmy Ibrahim , Ahmed Ibrahim Alsakka |
| 246 | 1 | 5 | _aاستخدام الديكسميديتومودين كمكمل علاجي لمرضى تسمم الحمل الذين يخضعون للعملية القيصرية تحت التخدير العام |
| 260 |
_aCairo : _bHeba Mahmoud Raafat , _c2014 |
||
| 300 |
_a85 Leaves : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Anesthesia | ||
| 520 | _aThe introduction of parenterally administered drugs in the obstetric population encounters many challenges. Such obstacles are imperative, as careless systemic administration of any medication may have a profound effect on both mother and fetus. Dexmedetomidine use in obstetric analgesia is being explored in view of its high lipophilicity. It is retained in the placental tissue, thereby resulting in less fetal transfer and a decreased incidence of fetal bradycardia | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAnalgesia | |
| 653 | 4 | _aDexmedetomidine | |
| 653 | 4 | _aHemodynamic | |
| 700 | 0 |
_aAhmed Ibrahim Alsakka , _eSupervisor |
|
| 700 | 0 |
_aJehan Helmy Ibrahim , _eSupervisor |
|
| 700 | 0 |
_aNadia Youssef Helmy , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c50912 _d50912 |
||